19-41337556-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000660.7(TGFB1):c.860+4327A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,034 control chromosomes in the GnomAD database, including 1,294 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1294 hom., cov: 31)
Consequence
TGFB1
NM_000660.7 intron
NM_000660.7 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -4.68
Publications
26 publications found
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.255 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFB1 | NM_000660.7 | c.860+4327A>G | intron_variant | Intron 5 of 6 | ENST00000221930.6 | NP_000651.3 | ||
| TGFB1 | XM_011527242.3 | c.863+4327A>G | intron_variant | Intron 5 of 6 | XP_011525544.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000221930.6 | c.860+4327A>G | intron_variant | Intron 5 of 6 | 1 | NM_000660.7 | ENSP00000221930.4 | |||
| TGFB1 | ENST00000600196.2 | c.712+4614A>G | intron_variant | Intron 4 of 5 | 5 | ENSP00000504008.1 | ||||
| TGFB1 | ENST00000677934.1 | c.635-5275A>G | intron_variant | Intron 3 of 4 | ENSP00000504769.1 | |||||
| TGFB1 | ENST00000598758.5 | n.148+4327A>G | intron_variant | Intron 1 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.121 AC: 18379AN: 151916Hom.: 1285 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
18379
AN:
151916
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.121 AC: 18433AN: 152034Hom.: 1294 Cov.: 31 AF XY: 0.120 AC XY: 8902AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
18433
AN:
152034
Hom.:
Cov.:
31
AF XY:
AC XY:
8902
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
7291
AN:
41454
American (AMR)
AF:
AC:
1433
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
316
AN:
3466
East Asian (EAS)
AF:
AC:
1376
AN:
5162
South Asian (SAS)
AF:
AC:
443
AN:
4828
European-Finnish (FIN)
AF:
AC:
936
AN:
10588
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6160
AN:
67972
Other (OTH)
AF:
AC:
272
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
804
1609
2413
3218
4022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
683
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.